Clinical Trial

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Study acronym: PROTECT-Fi
Recruiting
View on ClinicalTrials.gov →
Summary
The project is to explore in humans the hypothesis of the link between the alteration of tubulo-interstitial metabolism and the rate of deterioration of renal function by comparing various nephropathies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-28.
Status change: Not Yet Recruiting → Recruiting 2026-06-29
Trial Details
NCT Number NCT07010250
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: Ministry of Health, France, Institut National de la Santé Et de la Recherche Médicale, France, National Research Agency, France
Conditions ANCA Associated Vasculitis, Extramembranous Glomerulopathy, Nephrotic Syndrome, Minimal Change, Interstitial Nephritis, IgA Nephropathy, Segmental Hyalinosis, Diabetic Nephropathies
Enrollment 146 participants
Start Date 2025-11-03
Primary Completion 2029-11-02 (estimated)
Study Completion 2029-11-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-30